News
SABCS 2018: Can CTCs determine treatment for advanced breast cancer?
Results of the phase 3 STIC CTC trial will address the clinical utility of circulating tumor cells in choosing treatment approaches.
Results of the phase 3 STIC CTC trial will address the clinical utility of circulating tumor cells in choosing treatment approaches.
Using all three tests together for dementia screening yields more accurate results than any single test.
Truxima is the first biosimilar approved in the United States to treat non-Hodgkin lymphoma.
CHICAGO –
And study subjects face a terrifying choice: snacks or your smartphone?
SAN FRANCISCO – Findings reveal an opportunity for tools to facilitate discussions between transplant candidates and clinicians, and documentation...
LAS VEGAS – A review of over 300 laparoscopic hysterectomies revealed that obliteration of the posterior cul-de-sac makes the procedure even more...
Cortactin, a cytoskeleton-remodeling adapter protein, is expressed on most CLL cells, but not similar-appearing MCL cells.